Skip to content
Referral program is live — share your code, your friends save 5% and you earn 10% off your next order.
JetStreamPeptides
CARDIOGEN — JetStream Peptides research vial
Longevity Research

CARDIOGEN

$60.00

Short bioregulatory peptide studied for cardiomyocyte gene expression research.

Purity
>99%
Testing
3rd-party
Shipping
Tracked, discreet
$60.00Sold out
Size
1

Want to know when it's available? Text us and we'll let you know.

For laboratory research use only. Not for human consumption. Full disclaimer

Need the Certificate of Analysis for this batch? Request a COA.

About CARDIOGEN

Cardiac-targeted peptide bioregulator. Cardiomyocyte gene expression and cardiovascular tissue research.

Cardiogen is a synthetic tetrapeptide of sequence Ala-Glu-Asp-Arg, developed within the framework of peptide bioregulator research pioneered by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. Cardiogen belongs to a class of short organ-specific peptides — alongside compounds such as Epithalon (pineal), Vilon (thymus), and Hepatogen (liver) — theorized to act as tissue-targeted cytoprotective and gene-regulatory signals derived from the native peptidome of cardiac tissue. The bioregulator hypothesis proposes that these short peptides interact with chromatin and gene promoter regions in a tissue-selective manner, modulating transcription of genes involved in cellular repair, protein synthesis, and functional homeostasis within cardiomyocytes and vascular tissue. Cardiogen is studied in preclinical gerontological and cardiovascular research contexts for its proposed effects on cardiomyocyte function, cardiac tissue cytoprotection following ischemic or oxidative stress, vascular endothelial integrity, and age-related decline in myocardial performance — representing one of the more extensively documented compounds within the Eastern European peptide bioregulator research tradition.

Research applications

  • Cardiomyocyte gene expression modulation and cardiac tissue-selective peptide bioregulator mechanism research
  • Cardiac cytoprotection and myocardial recovery pathway research following ischemic or oxidative stress models
  • Vascular endothelial integrity and blood vessel homeostasis pathway investigation
  • Age-related myocardial performance decline and gerontological cardiovascular function research
  • Comparative organ-specific peptide bioregulator research within the Khavinson cytomedine framework

More in Longevity Research